Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
8,316 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02195141 | Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer | unknown | Phase 2 | 104 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01267695 | Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor | completed | Phase 2 | 20 | Peking UniversityOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02353260 | Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer | unknown | Phase 2 | 120 | Wei GuoOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT02350361 | Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. | unknown | Phase 2 / Phase 3 | 60 | Peking University Third HospitalOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT01578668 | Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases | completed | Phase 2 | 69 | Guangzhou Medical UniversityOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01588704 | Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma | completed | Phase 2 | 42 | Si-Yu WangOTHER | 1 | Jan 22, 2015 | clinicaltrials |
| NCT01998919 | A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. | completed | Phase 2 | 154 | Hoffmann-La RocheINDUSTRY | 8 | Jan 13, 2015 | clinicaltrials |
| NCT01690390 | Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02323737 | Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer | completed | Phase 2 | 62 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02324803 | Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients | unknown | Phase 2 | 86 | Southern China Urology Cancer ConsortiumOTHER | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01763385 | Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases(TRACTS) | unknown | Phase 2 | 210 | Wu Jieping Medical FoundationOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02185495 | Screening for Early Lung Cancer in Shanghai, China | unknown | Phase 2 | 3,000 | Shanghai Changzheng HospitalOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01781988 | Personalized Therapy in Non-small Cell Lung Cancer(PTINCLC) | completed | Phase 2 | 128 | Guangzhou Medical UniversityOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01207102 | Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 10 | Duke UniversityOTHER | 2 | Dec 15, 2014 | clinicaltrials |
| NCT02317224 | The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor(3-Hole) | unknown | Phase 2 | 240 | Tang-Du HospitalOTHER | 1 | Dec 15, 2014 | clinicaltrials |
| NCT02313051 | Everolimus trIal for Advanced prememopausaL Breast Cancer Patients(MIRACLE) | unknown | Phase 2 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01531452 | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer | completed | Phase 2 | 43 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00907582 | ASCT for Relapsed APL After Molecular Remission | terminated | Phase 2 | 5 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT02041338 | Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer | unknown | Phase 2 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02296658 | A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02093910 | Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy | unknown | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT02289378 | Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon-Plus) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT02291211 | S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis | unknown | Phase 2 | 60 | Tang-Du HospitalOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients(New Beat) | completed | Phase 2 | 25 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon) | completed | Phase 2 | 39 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT02284490 | High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases | unknown | Phase 2 | 25 | Rongjie TaoOTHER | 1 | Nov 6, 2014 | clinicaltrials |
| NCT02283489 | Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | unknown | Phase 2 | 180 | Renmiao ZhangINDUSTRY | 1 | Nov 5, 2014 | clinicaltrials |
| NCT02274584 | CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) | unknown | Phase 1 / Phase 2 | 20 | Peking UniversityOTHER | 2 | Oct 24, 2014 | clinicaltrials |
| NCT02272127 | Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer | unknown | Phase 2 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT02269904 | Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer. | unknown | Phase 2 | 120 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 21, 2014 | clinicaltrials |
| NCT02247609 | Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas(4SCAR19273) | unknown | Phase 1 / Phase 2 | 20 | Peking UniversityOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT02262897 | The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT02229682 | Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT02250209 | T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy | unknown | Phase 2 | 40 | Chinese PLA General HospitalOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT01424709 | Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)(BRAVO) | unknown | Phase 2 | 120 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT02241031 | Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia | unknown | Phase 2 / Phase 3 | 250 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Sep 16, 2014 | clinicaltrials |
| NCT00475670 | A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer | completed | Phase 2 | 44 | Hoffmann-La RocheINDUSTRY | 15 | Sep 15, 2014 | clinicaltrials |
| NCT01565538 | Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma | completed | Phase 2 | 123 | Si-Yu WangOTHER | 1 | Sep 15, 2014 | clinicaltrials |
| NCT02179528 | Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) | unknown | Phase 2 | 210 | Peking University Cancer Hospital & InstituteOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT01797900 | The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT | completed | Phase 2 | 130 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00912392 | Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 138 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Sep 3, 2014 | clinicaltrials |
| NCT01002092 | A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | unknown | Phase 2 | 160 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Sep 3, 2014 | clinicaltrials |
| NCT02229045 | Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer | unknown | Phase 2 | 37 | Sun Yat-sen UniversityOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT02226380 | FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer(FOLFOX6) | unknown | Phase 2 | 75 | Peking Union Medical College HospitalOTHER | 1 | Aug 27, 2014 | clinicaltrials |
| NCT02223611 | Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection(S1VSNP) | unknown | Phase 2 | 100 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT01403259 | SOX as Salvage Treatment in Nasopharyngeal Carcinoma | terminated | Phase 2 | 16 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT01914718 | Dose-adjusted EPOCH-R in MYC Positive DLBCL | terminated | Phase 2 | 26 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00919880 | Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer | completed | Phase 2 | 148 | Tao OUYANGOTHER | 1 | Aug 15, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials